Clinical Trial Update: Ketamine in Borderline Personality Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating ketamine for Borderline Personality Disorder was terminated; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Yale University | Conditions: Borderline Personality Disorder | Phase 2 | Status: TERMINATED | Results posted: 2023-06-26